Guidelines of care for the management of acne vulgaris

Cites (358)

Items 201–315 of 315

1. Development and Initial Validation of a Multidimensional Acne Global Grading System Integrating Primary Lesions and Secondary Changes
   Elena Bernardis, Haochang Shou, John S. Barbieri, Patrick J. McMahon, Marissa J. Perman, Leigh Ann Rola, Jenna L. Streicher, James R. Treat, Leslie A. Castelo‐Soccio, Albert C. Yan · 2020 · JAMA Dermatology
2. Isotretinoin and Risk of Inflammatory Bowel Disease: A French Nationwide Study
   Antoine Racine, Anne Cuerq, Anne Bijon, Philippe Ricordeau, Alain Weill, Hubert Allemand, O. Chosidow, Marie‐Christine Boutron‐Ruault, Franck Carbonnel · 2014 · The American Journal of Gastroenterology
3. Untitled work
   2014 · PubMed
4. Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program
   Rebecca M. Thiede, Supriya Rastogi, Beatrice Nardone · 2019 · International Journal of Women’s Dermatology
5. Oral isotretinoin for acne: a complete overview
   Villani, Alessia, Nastro, Francesca, Di Vico, Francesca, Fabbrocini, Gabriella, Annunziata, Maria Carmela, Genco, Lucia · 2022 · Expert Opinion on Drug Safety
6. Novel 1726 nm laser demonstrates durable therapeutic outcomes and tolerability for moderate-to-severe acne across skin types
   Macrene R. Alexiades, Amogh Kothare, David J. Goldberg · 2023 · Journal of the American Academy of Dermatology
7. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study
   Radhika Grandhi, Ali Alikhan · 2017 · Dermatology
8. Untitled work
   2016 · PubMed
9. Analysis of Facial Skin-Resident Microbiota in Japanese Acne Patients
   Shigeki Numata, Hirohiko Akamatsu, Narifumi Akaza, Akiko Yagami, Satoru Nakata, Kayoko Matsunaga · 2013 · Dermatology
10. Treatment of acne vulgaris during pregnancy and lactation: a Narrative review
    Ly, Sophia, Kamal, Kanika, Manjaly, Priya, Barbieri, John S., Mostaghimi, Arash · 2023 · Dermatology and Therapy
11. Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study
    Xia, Eric, Han, Jane, Faletsky, Adam, Baldwin, Hilary, Beleznay, Katie, Bettoli, Vincenzo, Dréno, Brigitte, Goh, Chee Leok, Stein Gold, Linda, Gollnick, Harald et al. · 2022 · JAMA Dermatology
12. An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris
    Jack Leiter Lesher, Dan K. Chalker, Jason G. Smith, Lyn Guenther, Charles N. Ellis, John J. Voorhees, Alan R. Shalita, Harry C. Klauda · 1985 · Journal of the American Academy of Dermatology
13. Evaluating and treating the adult female patient with acne.
    Joshua Zeichner · 2013 · PubMed
14. A novel 1726-nm laser system for safe and effective treatment of acne vulgaris
    Matteo Giuseppe Scopelliti, Amogh Kothare, Michael Karavitis · 2022 · Lasers in Medical Science
15. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials
    Emil A Tanghetti, William Werschler, Terry Lain, Eric Guenin, Gina Martin, Radhakrishnan Pillai · 2019 · Journal of Drugs in Dermatology
16. Untitled work
    2014 · PubMed
17. Topically applied erythromycin in inflammatory acne vulgaris
    Joel E. Bernstein, Alan R. Shalita · 1980 · Journal of the American Academy of Dermatology
18. Efficacy and tolerability of low-dose spironolactone and topical benzoyl peroxide in adult female acne: a randomized, double-blind, placebo-controlled trial
    Patiyasikunt, Mattana, Chancheewa, Bussabong, Asawanonda, Pravit, Noppakun, Nopadon, Kumtornrut, Chanat · 2020 · The Journal of Dermatology
19. Long-term use of spironolactone for acne in women: A case series of 403 patients
    Vaibhav Garg, Juliana K. Choi, William D. James, John S. Barbieri · 2021 · Journal of the American Academy of Dermatology
20. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline.
    Mohsen Alirezaï, Sheru A George, Ian Coutts, Diane I. Roseeuw, Jean Pierre Hachem, Nabil Kerrouche, Farzaneh Sidou, Pascale Soto · 2007 · PubMed
21. A Placebo-Controlled Clinical Trial to Compare a Gel Containing a Combination of Isotretinoin (0.05%) and Erythromycin (2%) with Gels Containing Isotretinoin (0.05%) or Erythromycin (2%) alone in the Topical Treatment of Acne vulgaris
    D. Glass, G.C. Boorman, Graeme I Stables · 1999 · Dermatology
22. Spironolactone and cytochrome P-450: impairment of steroid hydroxylation in the adrenal cortex
    Menard, Raymond H., Martin, Horace F., Stripp, Bitten, Gillette, James R., Bartter, Frederic C. · 1974 · Life Sciences
23. Quantitative PCR of Propionibacterium acnes DNA in samples aspirated from sebaceous follicles on the normal skin of subjects with or without acne.
    Yuriko Miura, Ikuo Ishige, Naomi Soejima, Yoshimi Suzuki, Keisuke Uchida, Seiji Kawana, Yoshinobu Eishi · 2010 · PubMed
24. Untitled work
    2014 · PubMed
25. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
    Linda F Stein Gold, Michael T Jarratt, Alicia D Bucko et al. · 2016 · PubMed
26. Double-Blind Study of Doxycycline in Acne Vulgaris
    Gerd Plewig · 1970 · Archives of Dermatology
27. Inferences in microbial structural signatures of acne microbiome and mycobiome
    Jubin Kim, Taehun Park, Hye-Jin Kim, Susun An, Woo Jun Sul · 2021 · The Journal of Microbiology
28. Safety and efficacy of fixed‐dose 10 mg daily isotretinoin treatment for acne vulgaris in Malaysia
    Felix Boon‐Bin Yap · 2016 · Journal of Cosmetic Dermatology
29. Untitled work
    2011 · PubMed
30. Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin
    Shari Wright, Andrew Strunk, Amit Garg · 2020 · Journal of the American Academy of Dermatology
31. Differences of Microbiomes Found in Non-Inflammatory and Inflammatory Lesions of Acne Vulgaris.
    Nelva Karmila Jusuf, Imam Budi Putra, Lovena Sari · 2020 · PubMed
32. Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data
    Paljarvi, Tapio, McPherson, Tess, Luciano, Sierra, Herttua, Kimmo, Fazel, Seena · 2022 · British Journal of Dermatology
33. Objective assessment of acne
    Markus Becker, Thomas Wild, Christos C. Zouboulis · 2016 · Clinics in Dermatology
34. Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris
    J. Michael Maloney, Deborah I. Arbit, Mary Flack, Constance McLaughlin-Miley, Cynthia Sevilla, Richard J. Derman · 2001 · Clinical Journal of Women s Health
35. Untitled work
    2018 · PubMed
36. Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.
    2019 · Europe PMC (PubMed Central)
37. Untitled work
    2006 · PubMed
38. The association between drospirenone and hyperkalemia: a comparative-safety study
    Steven T. Bird, Salvatore R Pepe, Mahyar Etminan · 2011 · BMC Clinical Pharmacology
39. Interaction of spironolactone with rat skin androgen receptor
    Boisselle, Andrée, Dionne, France T., Tremblay, Roland R. · 1979 · Canadian Journal of Biochemistry
40. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Emil A Tanghetti, Sunil Dhawan, L Green · 2011 · PubMed
41. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older.
    Stephen Keith Tyring, Leon Kircik, David M. Pariser, Eric Guenin, Varsha Rajat Bhatt, Radhakrishnan Pillai · 2018 · PubMed
42. Should dermatologists prescribe hormonal contraceptives for acne?
    Harper, Julie C. · 2009 · Dermatologic Therapy
43. Quality of life assessed using Skindex-16 scores among patients with acne receiving isotretinoin treatment
    Secrest, Aaron M., Hopkins, Zachary H., Frost, Zachary E., Taliercio, Vanina L., Edwards, LaVar D., Biber, Joshua E., Chen, Suephy C., Chren, Mary-Margaret, Ferris, Laura K., Kean, Jacob et al. · 2020 · JAMA Dermatology
44. Acne, sexual orientation, and mental health among young adults in the United States: A population-based, cross-sectional study
    Yi Gao, Esther K. Wei, Sarah T. Arron, Eleni Linos, David J. Margolis, Matthew D. Mansh · 2017 · Journal of the American Academy of Dermatology
45. Effect of a desogestrel-containing oral contraceptive on the skin
    H. Irving Katz, Steven E. Kempers, Mark Akin, F E DUNLAP, D. Whiting, T.C.J. Norbart · 2000 · The European Journal of Contraception & Reproductive Health Care
46. Water-based versus alcohol-based benzoyl peroxide preparations in the treatment of acne vulgaris
    Fyrand, Ole, Bang Jakobsen, Henny · 2009 · Dermatologica
47. Comparison of oral azithromycin with oral doxycycline in the treatment of acne vulgaris.
    Ghafoor Ullah, Sahibzada Mehmood Noor, Zubair Bhatti · 2014 · PubMed
48. Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: analysis of a large commercial insurance claims database
    Ugonabo, Nkemjika, Love, Elyse, Wong, Priscilla W., Rieder, Evan A., Orlow, Seth J., Kim, Randie H., Nagler, Arielle R. · 2021 · Journal of the American Academy of Dermatology
49. Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris.
    Jerry K.L. Tan, Linda Stein Gold, Joel Schlessinger · 2012 · PubMed
50. Risk of psychiatric disorders in patients taking isotretinoin: a nationwide, population-based, cohort study in Taiwan
    Chen, Yi-Hsien, Wang, Wei-Ming, Chung, Chi-Hsiang, Tsao, Chang-Huei, Chien, Wu-Chien, Hung, Chih-Tsung · 2022 · Journal of Affective Disorders
51. Untitled work
    2011 · PubMed
52. Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris.
    G Krishnan · 1976 · PubMed
53. Topical Tretinoin, Vitamin A Acid (Airol®) in Acne vulgaris
    Jørgen V. Christiansen, Ejnar Gadborg, Knud Ludvigsen et al. · 2009 · Dermatologica
54. Endocrine parameters in acne vulgaris.
    Jolanta B. Schmidt, A Lindmaier, J. Spona · 1990 · PubMed
55. Influence of contraception class on incidence and severity of acne vulgaris
    Barbieri, John S., Mitra, Nandita, Margolis, David J., Harper, Cynthia C., Mostaghimi, Arash, Abuabara, Katrina · 2020 · Obstetrics & Gynecology
56. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris
    Emil A Tanghetti, Leon Kircik, Lawrence J. Green, Eric Guenin, Susan Harris, Gina Martin, Radhakrishnan Pillai · 2019 · PubMed
57. Untitled work
    2012 · PubMed
58. Untitled work
    2013 · PubMed
59. Depression screening using health questionnaires in patients receiving oral isotretinoin for acne vulgaris
    Schrom, Kory, Nagy, Terri, Mostow, Eliot · 2016 · Journal of the American Academy of Dermatology
60. Is there an association between isotretinoin therapy and adverse mood changes? A prospective study in a cohort of acne patients
    Bray, Adam P., Kravvas, Georgios, Skevington, Suzanne M., Lovell, Christopher R. · 2019 · Journal of Dermatological Treatment
61. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Aurora Guerra‐Tapia · 2012 · PubMed
62. Is benzoyl peroxide 3% topical gel effective and safe in the treatment of acne vulgaris in J apanese patients? A multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study
    Makoto Kawashima, Hirofumi Hashimoto, Alessandra B Alió Saenz · 2014 · The Journal of Dermatology
63. Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone
    Hayley Braun, Qi Zhang, Darios T Getahun, Michael Jonah Silverberg, Vin Tangpricha, Michael G Goodman, Howa Yeung · 2021 · JAMA Dermatology
64. Role of growth hormone and insulin-like growth factor-I in hyperandrogenism and the severity of acne vulgaris in young males
    Basil Oied Mohammed Saleh · 2012 · Saudi Medical Journal
65. Evolution of acne assessments and impact on acne medications: An evolving, imperfect paradigm
    Linda Stein Gold, Jerry K.L. Tan, Leon Kircik · 2016 · Journal of the American Academy of Dermatology
66. Erythromycin 2 percent gel in the treatment of acne vulgaris.
    Peter E. Pochi, Fillmore K. Bagatell, Charles N. Ellis, Richard B. Stoughton, Whitmore Cg, Saatjian Gd, John Sefton · 1988 · PubMed
67. Efficacy and safety comparison of combination of 0.04% tretinoin microspheres plus 1% clindamycin versus their monotherapy in patients with acne vulgaris: a phase 3, randomized, double-blind study
    Sunil Dogra, T K Sumathy, Chitra Shivanand Nayak, Gowthamkarthic Ravichandran, Pradyumna Vaidya, Suyog C. Mehta, Ruchika Mittal, Amey Mane, Sujeet Narayan Charugulla · 2020 · Journal of Dermatological Treatment
68. Untitled work
    2012 · PubMed
69. A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial
    Unnop Jaisamrarn, Somsak Chaovisitsaree, Surasak Angsuwathana · 2014 · Contraception
70. A randomized controlled trial of topical benzoyl peroxide 2.5% gel with a low glycemic load diet versus topical benzoyl peroxide 2.5% gel with a normal diet in acne (grades 1-3)
    Upadya, GathaM, Pavithra, G, Rukmini, MS · 2019 · Indian Journal of Dermatology, Venereology and Leprology
71. Is routine laboratory testing in healthy young patients taking isotretinoin necessary: a critically appraised topic
    Affleck, Andrew, Jackson, David, Williams, Hywel C., Chavez, Patricia, Albrecht, Joerg · 2022 · British Journal of Dermatology
72. Untitled work
    1978 · PubMed
73. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide
    Dubina, Meghan I., Fleischer, Alan B. · 2009 · Archives of Dermatology
74. Benzoyl peroxide lotion (20 percent) in acne.
    E B Smith, R. Steven Padilla, Jack M. Mccabe, L E Becker · 1980 · PubMed
75. Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups
    Harper, Julie C, Roberts, Wendy E, Zeichner, Joshua A, Guenin, Eric, Bhatt, Varsha, Pillai, Radhakrishnan · 2020 · Journal of Dermatological Treatment
76. Dermatologist Use of Intralesional Triamcinolone in the Treatment of Acne.
    Tara Gallagher, Mark Taliercio, John K Nia · 2020 · PubMed
77. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris.
    Fran E. Cook-Bolden · 2015 · Europe PMC (PubMed Central)
78. Untitled work
    2006 · PubMed
79. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
    Jonathan Weiss, Linda Stein Gold, Matthew J. Leoni, María José Rueda, Hong Liu, Emil A Tanghetti · 2015 · PubMed
80. Untitled work
    1976 · PubMed
81. Temporal Trends and Clinician Variability in Potassium Monitoring of Healthy Young Women Treated for Acne With Spironolactone
    John S. Barbieri, David J. Margolis, Arash Mostaghimi · 2021 · JAMA Dermatology
82. Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study
    Bushra Kassem, Mohammad Ismail, Fouz Hassan · 2022 · Dermatologic Therapy
83. Do tutorials on application method enhance adapalene–benzoyl peroxide combination gel tolerability in the treatment of acne?
    Hyuck Hoon Kwon, Seon Yong Park, Ji Young Yoon, Seonguk Min, Dae Hun Suh · 2015 · The Journal of Dermatology
84. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender.
    Linda Stein Gold, William Philip Werschler, Jennifer A. Mohawk · 2017 · PubMed
85. Acne Vulgaris in Skin of Color: A Systematic Review of the Effectiveness and Tolerability of Current Treatments.
    Pirunthan Pathmarajah, Elizabeth Peterknecht, Karmen Cheung · 2022 · PubMed
86. A provider global assessment quality measure for clinical practice for inflammatory skin disorders
    Alice Bendix Gottlieb, Nicole Salame, April Wang Armstrong, Joseph Frank Merola, Sylvia L. Parra, Junko Takeshita, Suephy C. Chen, John Latella, Marta J. Van Beek · 2018 · Journal of the American Academy of Dermatology
87. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety
    Edward L. Lain, Doris Day, Julie C Harper · 2019 · PubMed
88. Use of oral isotretinoin to treat acne in the public system: a hospital-based retrospective cohort
    Evaristo, Letícia Santos Berbert Faria, Bagatin, Ediléia · 2019 · Sao Paulo Medical Journal
89. The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
    Julie C Harper · 2015 · PubMed
90. The patient‐centered acne severity scale study
    Deepa P. Patel, Elena Bernardis, Albert C. Yan · 2017 · Pediatric Dermatology
91. Active Comparator Trial Designs Used to Promote Development of Innovative New Medications
    John S. Barbieri, Jerry K.L. Tan, Adewole S. Adamson · 2020 · Cutis
92. Analysis of trends and status of physician‐based evaluation methods in acne vulgaris from 2000 to 2019
    Soo Ick Cho, Ji Hoon Yang, Dae Hun Suh · 2020 · The Journal of Dermatology
93. Nasal antibiotic‐resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey
    ERGIN, Çağrı, ERGIN, Şeniz, KALELI, İlknur, KAÇAR, Nida, ŞENGÜL, Mustafa, ERDOĞAN, Berna Ş. · 2006 · The Journal of Dermatology
94. Untitled work
    2020 · PubMed
95. Use of Active Comparator Trials for Topical Medications in Dermatology
    John P. Miller, Sophia Ly, Arash Mostaghimi · 2021 · JAMA Dermatology
96. Association Of Serum Testosterone And Sex Hormone Binding Globulin Levels In Females With Acne Based On Its Severity.
    2016 · PubMed
97. Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.
    Michael H. Gold, Andrew R. Korotzer · 2015 · PubMed Central
98. Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex.
    Lawrence J Green, James Q Del Rosso, Emil A Tanghetti · 2021 · PubMed
99. Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations.
    Linda Stein Gold · 2015 · PubMed
100. Comparison of pneumatic broadband light plus adapalene gel 0.3% versus adapalene gel 0.3% monotherapy in the treatment of mild to moderate acne.
     Chinmanat Tangjaturonrusamee, Pinyo Rattanaumpawan, Chérie M. Ditre · 2016 · PubMed
101. Prioritizing treatment outcomes: How people with acne vulgaris decide if their treatment is working
     Alison Layton, Heather Whitehouse, E.A. Eady · 2017 · Journal of Evidence-Based Medicine
102. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability
     Linda Stein Gold, David M. Pariser, Eric Guenin · 2019 · PubMed
103. Eligibility Criteria Related to Hormone Therapy in Acne Clinical Trials: A Systematic Review
     Taryn M. DeGrazia, Robin Rolader, Diane M. Thiboutot · 2020 · Journal of Investigative Dermatology
104. Granuloma annulare. Report of a case treated successfully by intralesional triamcinolone injection.
     H Seif-El-Nasr, El-Komy Hm · 1962 · PubMed
105. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females
     Julie C Harper, Hilary E. Baldwin, Linda Stein Gold · 2019 · PubMed
106. Second joint position paper: Use of isotretinoin in severe acne
     Minerva Gómez‐Flores, David Eduardo Poletti-Vázquez, Linda García‐Hidalgo · 2019 · PubMed
107. Isotretinoin Exposure and Risk of Celiac Disease
     Shadi Rashtak, Shahryar Khaleghi, Eric Vincent Marietta, Mark R. Pittelkow, Joseph J. Larson, Brian D. Lahr, Joseph A. Murray · 2015 · PLoS ONE
108. Tazarotene 0.045% Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis.
     Hilary E. Baldwin, Lawrence J. Green, Leon Kircik, Eric Guenin, Anya Loncaric, Radhakrishnan Pillai · 2021 · PubMed Central
109. Supplemental Material for "Psychiatric Disorders and Suicidal Behavior in Patients with Acne Prescribed Oral Antibiotics versus Isotretinoin: Analysis of a Large Commercial Insurance Claims Database"
     N. Ugonabo, E. Love, Priscilla W. Wong · 2021
110. Clinical safety and efficacy comparison of adapalene gel and Retin-A gel in the treatment of acne vulgaris
     A Shalita · 1995 · Journal of the European Academy of Dermatology and Venereology
111. Skin Microbiome and Acne Vulgaris: Staphylococcus, a New Actor in Acne
     B Dreno, R Martin, A Khammari · 2017 · SKIN The Journal of Cutaneous Medicine
112. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized Phase 2 and Phase 3 Studies of the First Triple-Combination Drug
     Linda Stein Gold, Leon Kircik, Emil Tanghetti, Hilary Baldwin, Michael Gold, Zoe Draelos, Edward Lain, David Pariser, Neil Sadick, Radhakrishnan Pillai et al. · 2023 · SKIN The Journal of Cutaneous Medicine
113. 188 Patient-reported outcome measures for health-related quality of life in acne vulgaris: A systematic review of measure development and measurement properties
     Z. Hopkins, D. Thiboutot, L. Perez Chada, H.A. Homsi, J.S. Barbieri · 2022 · Journal of Investigative Dermatology
114. 13674 Eligibility criteria related to hormone therapy in acne clinical trials
     Taryn DeGrazia, Robin Rolader, Diane Thiboutot, Howa Yeung · 2020 · Journal of the American Academy of Dermatology
115. Long-term Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study
     David M Pariser, Lawrence J. Green, Edward L. Lain, Jodi L. Johnson, Ayman Grada · 2020 · SKIN The Journal of Cutaneous Medicine